PopVax awarded $2M for its patch-delivered mRNA influenza vaccine in collaboration with LTS Lohmann as part of BARDA’s Patch Forward Prize.

There exist many other protein screening platforms that allow for studying protein–protein interactions (Figure 2). Here, we briefly summarize the principles of some widely used screening ...

LUTHOR HD 3’mRNA-seq libraries display comprehensive transcription profiles, enabling high-definition gene expression characterization from single eukaryotic cells, cell biopsies, or purified ...

The issuer is solely responsible for the content of this announcement.

ANDERNACH, GERMANY - Newsaktuell - 14 January 2025 - LTS LOHMANN Therapie-Systeme AG (LTS), a leading <a target=_blank href= ...

PopVax, an Indian biotechnology company, won $2 million from BARDA for its innovative mRNA influenza vaccine. Developed in partnership with Germany's LTS Lohmann, the vaccine utilizes a unique ...